Bringing the fundamentals into focus…
Back to Neurocrine Biosciences, Inc.
How Neurocrine Biosciences, Inc. stacks up
NBIX · against 126 other Healthcare companies of similar size
Profitability
91/ 100
Near the top of its peers.
Ranked #22 of 127 · scores higher than 83% of peers
Bars: peers in each 10-point band of the profitability score26 peers with a profitability score of 90–100, including NBIX · Click a bar to see the companies
Why profitability scores 91?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its return on assets, operating margin and return on invested capital, which are stronger than most Healthcare peers.
- a higher return on invested capital: stronger than 85% of peers. Return on invested capital: 18.7% vs peer median 4.7%
- a wider operating margin: stronger than 86% of peers. Operating margin: 23.6% vs peer median 7.1%
- a higher return on assets: stronger than 94% of peers. Return on assets: 13.2% vs peer median 1.7%
Metric by metric
Position: dot = NBIX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NBIX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 122 reported | 18.7% | 10.5% | 78% | 33% | |
| Operating marginHigher is better · 125 reported | 23.6% | 15.2% | 80% | 33% | |
| Return on assetsHigher is better · 124 reported | 13.2% | 6.1% | 87% | 33% | |
| Return on equityHigher is better · 120 reported | 22.1% | 11.4% | 80% | Context only | |
| Gross marginHigher is better · 131 reported | 64.5% | 58.9% | 58% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around NBIX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 13.9B EUR (≈$15.3B) | 99 | 78 | |
| 1 | 20.0B AUD (≈$13.2B) | 99 | 77 | |
| 4 | 23.8B USD | 98 | 84 | |
| 5 | 193.6B HKD (≈$24.8B) | 97 | 78 | |
| 15 | 921.9B INR (≈$11.1B) | 94 | 82 | |
| 19 | 80.2B CNY (≈$11.2B) | 93 | 76 | |
| 19 | 2.67T INR (≈$32.1B) | 93 | 68 | |
| 21 | 12.6B EUR (≈$13.9B) | 92 | 73 | |
| 22 | 16.8B USD | 91 | 75 | |
| 22 | 28.6B USD | 91 | 60 | |
| 24 | 10.7B USD | 90 | 65 | |
| 24 | 16.1B CHF (≈$18.5B) | 90 | 54 | |
| 24 | 21.5B USD | 90 | 60 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score